Humoral Immune Response to SARS-CoV-2 in Iceland

20201,037 citationsJournal Articlegreen Open Access

Authors

Daníel F. Guðbjartsson · Girls Incorporated

Gudmundur L. Norddahl · Girls Incorporated

Páll Melsted · Girls Incorporated

Kristbjörg Gunnarsdóttir · Girls Incorporated

Hilma Hólm · Girls Incorporated

Elías Eyþórsson · Girls Incorporated

Asgeir Ö. Arnthórsson ·

Abstract

Our results indicate that antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis. We estimate that the risk of death from infection was 0.3% and that 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by qPCR.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Long-Term Effects of COVID-19

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 383, Issue 18, pp. 1724-1734

DOI: 10.1056/nejmoa2026116

Field-Weighted Citation Impact: 25.30